Revolade (Eltrombopag) is a medication used to increase platelet counts in patients with conditions that cause low platelets, helping reduce bleeding risk and improve overall stability.
What is Revolade (Eltrombopag)?
Revolade belongs to a class of drugs known as Thrombopoietin Receptor Agonists (TPO receptor agonists).
It works by stimulating the bone marrow to produce more platelets, helping to:
- Increase platelet count
- Reduce the risk of bleeding
- Improve stability in chronic low platelet conditions
In simple terms:
It helps the body produce platelets more effectively.
Indications
Revolade (Eltrombopag) is used in:
- Chronic Immune Thrombocytopenia (ITP)
- Certain cases of aplastic anemia
- Low platelet counts associated with specific diseases or treatments
Dosage and Administration
- Standard dose: 50 mg once daily
- Taken orally
- Must be used according to physician instructions
- Dose may vary depending on lab results and patient response
Common Side Effects
May include:
- Headache
- Nausea
- Fatigue
- Elevated liver enzymes
- Muscle pain
- Mild digestive disturbances
Regular monitoring is important during treatment.
Monitoring During Treatment
Patients on Revolade (Eltrombopag) require:
- Platelet count monitoring
- Liver function tests
- Complete blood count (CBC)
- Evaluation of treatment response
Availability & How to Access Treatment
Revolade (Eltrombopag) is available through Macrocare’s approved partners.
You can now request and access the medication easily through us.
WhatsApp contact for medication requests:
Click here
Revolade (Eltrombopag) Revolade (Eltrombopag) 50 mg is an effective treatment that helps increase platelet counts and reduce bleeding risks in patients with chronic thrombocytopenia.
Medical Disclaimer:
This content is for educational purposes only and does not replace professional medical advice. Treatment decisions should always be made by a qualified physician.
